A successful Slenyto Launch symposium in France

Around 120 Child and Adolescent Psychiatrists participated in Biocodex launch symposium during the French Psychiatry Congress in December 2019.

The launch symposium included 3 lectures by influential KOLs:

  • Sleep in children with ASD – Prof. Richard Delorme, Robert Debré Hospital, Paris
  • How to treat sleep disorders in children with ASD? – Prof. Sylvie Tordjman, Guillaume Régnier Hospital, Rennes
  • What is the role of melatonin treatment ? – Prof. Carmen Schröder, University Hospital Strasbourg

Prof. Schröder presented Slenyto as THE treatment for ped-ASD insomnia, created as a response to European Medicine Agency demand. She precised that there is no therapeutic alternative and detailed Slenyto clinical trial results, including treatment response evaluation and dosage titration regimen.

All three lectures generated high interest : followed by many questions and visits at Biocodex booth after the symposium.


  • Text size: A A A
  • Circadin
  • Recent news

    • Slenyto (PedPRM) is now available in France!
    • Slenyto (PedPRM) is now available in Denmark!
    • Slenyto (PedPRM) is now also available in Iceland!
  • Partners